Karyopharm Therapeutics

Karyopharm Therapeutics is a clinical-stage pharmaceutical company. The company is focused on the discovery, development, and commercialization of drugs directed against nuclear transport targets for the treatment of cancer and other diseases. The company has discovered and is developing small molecule Selective Inhibitors of Nuclear Export (SINE), compounds that inhibit the nuclear export protein (XPO1). The company's SINE compounds were the first oral XPO1 inhibitors in clinical development. The company is also focusing on commercializing its primary drug candidate, selinexor, as an oral agent in cancer indications with significant unmet clinical need, initially for hematologic malignancies.
  • TickerKPTI
  • ISINUS48576U1060
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Wedbush Research

Wedbush Morning Call - July 5, 2019

David Nierengarten ...
  • Jeffrey La Rosa

XPOVIO Approved for Refractory Multiple Myeloma Despite FDA Panel

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Wedbush Research

Wedbush Morning Call - July 5, 2019

David Nierengarten ...
  • Jeffrey La Rosa

XPOVIO Approved for Refractory Multiple Myeloma Despite FDA Panel

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

ValuEngine Rating and Forecast Report for KPTI

ResearchPool Subscriptions

Get the most out of your insights

Get in touch